Anal Cancer Symptoms: 7 Key Signs To Watch For

Anal cancer develops in the cells lining the anal canal, a short tube at the end of the rectum measuring about 1.5 inches in length, surrounded by sphincter muscles that control bowel movements. Though rare, it can cause noticeable symptoms such as rectal bleeding, anal pain, and changes in bowel habits, often mistaken for hemorrhoids or other common conditions. Early recognition of these signs is crucial, as most cases are linked to human papillomavirus (HPV) infection and are highly treatable when caught early through chemotherapy and radiation rather than surgery.

What Is Anal Cancer?

Anal cancer refers to the uncontrolled growth of abnormal cells in the anal canal or surrounding tissues, classified into anal canal cancers (inside the canal) and anal margin cancers (on the external skin). It forms a tumor that may invade nearby tissues or, rarely, metastasize to distant sites like the liver or lungs. Unlike more common colorectal cancers, anal cancer arises from squamous cells in most cases and is strongly associated with persistent HPV infection, particularly high-risk strains. The disease is uncommon, affecting about 1-2 per 100,000 people annually, but incidence is rising due to increased HPV prevalence. Healthy cells follow DNA instructions to grow, divide, and die orderly; cancer cells ignore these, multiplying rapidly and forming masses that disrupt normal function.

Historically, treatment involved extensive surgery like abdominoperineal resection, creating a permanent colostomy. Modern approaches favor chemoradiation, preserving sphincter function in up to 90% of early-stage cases. Prognosis is excellent for localized disease, with five-year survival rates exceeding 80%, emphasizing the importance of symptom awareness.

Anal Cancer Symptoms

Symptoms of anal cancer often mimic benign issues like hemorrhoids, fissures, or infections, leading to delays in diagnosis. They typically appear in later stages, as early cancer may be asymptomatic. Common signs include:

• Rectal or anal bleeding: Bright red blood on toilet paper, in the stool, or dripping into the bowl, often the first noticeable symptom.
• Anal pain or discomfort: Sharp, burning, or aching pain during bowel movements, sitting, or at rest; may worsen with tumor growth.
• A lump or mass: A firm growth near the anus or in the canal, sometimes ulcerated or palpable.
• Anal itching (pruritus ani): Persistent irritation, sometimes due to mucus discharge or skin changes.
• Changes in bowel habits: Increased urgency, frequency, diarrhea, constipation, or narrower stools due to obstruction.
• Discharge or drainage: Mucus, pus, or blood from the anus, indicating tumor breakdown.
• Redness or inflammation: Swelling around the anus, pressure sensations, or tenesmus (feeling of incomplete evacuation).

These symptoms can vary by tumor location and size. Anal margin tumors may present as skin lesions resembling warts or ulcers, while canal tumors cause more internal pressure. Women may experience symptoms alongside vaginal discharge if the tumor affects adjacent tissues. Not all symptoms indicate cancer—many resolve with over-the-counter treatments—but persistence beyond two weeks warrants evaluation.

Anal Cancer Causes and Risk Factors

The primary cause of anal cancer is DNA mutations in anal canal cells, driven mainly by high-risk HPV strains (e.g., HPV-16, HPV-18), which account for 80-90% of cases. HPV spreads via skin-to-skin contact during anal sex or other intimate activities; most infections clear naturally, but persistent ones cause cellular changes leading to dysplasia and cancer.

Key risk factors include:

• Receptive anal intercourse: Increases HPV exposure and microtears, elevating risk up to 17-fold in some studies.
• Immunosuppression: HIV/AIDS, organ transplants, or immunosuppressive drugs weaken defenses against HPV.
• Smoking: Tobacco carcinogens impair immune clearance of HPV and damage DNA.
• Prior cancers: History of cervical, vulvar, vaginal, or bowel cancer raises risk due to shared HPV etiology.
• Multiple sexual partners: Heightens HPV acquisition.
• Age and gender: More common in women over 60, though rising in younger adults.

Non-HPV cases may stem from chronic inflammation or fistulas. HPV vaccination (Gardasil) prevents most high-risk strains, reducing incidence by up to 50% in vaccinated populations.

When to See a Doctor

Consult a healthcare provider promptly if you experience unexplained anal symptoms lasting more than a week, especially bleeding, pain, or lumps. Do not self-diagnose as hemorrhoids—early anal cancer is curable, but delays allow spread. High-risk individuals (e.g., MSM, HIV-positive, HPV history) should seek screening even without symptoms. Urgent red flags include heavy bleeding, severe pain, weight loss, or bowel obstruction. Providers are experienced with these discussions; timely evaluation via exam or tests can rule out cancer or enable early intervention.

How Is Anal Cancer Diagnosed?

Diagnosis begins with a medical history focusing on symptoms, sexual history, smoking, and HPV exposure. Physical exams include:

• Digital rectal exam (DRE): Gloved finger checks for masses, tenderness, or irregularities.
• Anoscopy/proctoscopy: Illuminated scopes visualize the canal.
• Anal Pap test: Swab detects abnormal (dysplastic) cells.
• HPV testing: Confirms high-risk strains in anal cells.
• Biopsy: Tissue sample examined microscopically for cancer confirmation.
• Imaging: CT, MRI, PET scans stage spread; endoanal ultrasound assesses depth.

Staging ranges from 0 (dysplasia) to IV (metastatic), guiding treatment. No routine population screening exists, but high-risk groups benefit from annual anal Paps. Differential diagnosis excludes hemorrhoids, fissures, abscesses, IBD, or STIs.

Anal Cancer Treatment

Treatment is stage-dependent, prioritizing organ preservation. Localized disease (80% of cases) uses chemoradiation: 5-fluorouracil/mitomycin-C with radiation, achieving 80-90% cure rates without surgery. Advanced stages may require surgery (local excision or APR), immunotherapy (e.g., nivolumab), or palliative care. Post-treatment monitoring includes imaging and exams for 5 years, as tumors may shrink slowly. HPV vaccination and smoking cessation aid prevention and outcomes.

Anal Cancer Prevention

Prevent via HPV vaccination (ages 9-45), condom use, smoking cessation, HIV management, and routine screenings for high-risk groups. Safe sex reduces transmission; dysplasia surveillance prevents progression.

Frequently Asked Questions (FAQs)

Can anal cancer be cured if caught early?

Yes, early-stage anal cancer has a 5-year survival rate over 80% with chemoradiation, often avoiding surgery.

Is anal cancer caused by HPV?

Most cases (80-90%) link to high-risk HPV; vaccination prevents it.

Are anal cancer symptoms always obvious?

No, early symptoms mimic hemorrhoids; screening is key for high-risk individuals.

Who is at highest risk for anal cancer?

Those with receptive anal sex, HIV, smoking history, or prior HPV-related cancers.

Does anal cancer spread quickly?

Rarely; most stay local, but metastasis to liver/lungs is harder to treat.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to renewcure,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete